Related Experiment Video
Updated: Aug 23, 2025

09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.2K
Tumor budding is a valuable prognostic parameter in endometrial carcinomas
1Department of Pathology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey.
Indian Journal of Pathology & Microbiology
|October 29, 2022
Summary
Tumor budding (TB) is a significant indicator of poor prognosis in endometrial cancer. This study found that the presence of TB negatively impacts overall survival, even in early-stage disease, highlighting its value as a prognostic marker.
Area of Science:
- Gynecologic Oncology
- Pathology
- Cancer Research
Background:
- Tumor budding (TB) is a recognized morphological feature associated with prognosis in various cancers.
- Its specific role in endometrial carcinoma requires further elucidation.
Purpose of the Study:
- To investigate the prognostic significance of tumor budding in endometrial carcinomas.
- To determine if TB impacts overall survival in endometrial cancer patients.
Main Methods:
- A cohort of 211 endometrial cancer cases diagnosed between 2008-2015 with at least 5 years of follow-up were analyzed.
- Hematoxylin and eosin stained slides were re-evaluated for the presence and status of tumor budding.
- Statistical analyses included nonparametric tests, Kaplan-Meier, Log-rank test, and Cox regression.
Main Results:
- Tumor budding correlated significantly with larger tumor diameter, non-endometrioid histology, mixed cell types, higher tumor grade, deeper myometrial invasion, cervical stromal invasion, advanced pT stage, lymph node involvement, lymphovascular invasion, and advanced overall stage.
- The presence of TB was associated with a significantly worse 5-year overall survival (OS).
- Even in early-stage (grade 1, pT1, stage 1) endometrial carcinomas, TB presence decreased OS rates.
Conclusions:
- Tumor budding is an adverse prognostic factor in endometrial carcinoma.
- TB status adversely affects patient prognosis and overall survival.
- Tumor budding should be considered a valuable prognostic parameter in endometrial cancer management.
Related Concept Videos
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K

